Status:
COMPLETED
Mindray Pediatric Hematology Reference Intervals Study
Lead Sponsor:
The Hospital for Sick Children
Collaborating Sponsors:
MINDRAY
Conditions:
Establish Hematology Reference Intervals
Eligibility:
All Genders
Up to 18 years
Brief Summary
This study is a collaborative initiative between the CALIPER (Canadian Laboratory Initiative on Pediatric Reference Intervals) program at the Hospital for Sick Children (HSC) and Mindray Medical Inter...
Detailed Description
The purpose of this study is to establish accurate and robust ethnic-, age- and sex-specific reference intervals for hematology parameters during childhood and adolescence on the Mindray analyzer (BC-...
Eligibility Criteria
Inclusion
- 0-\<19 years
Exclusion
- History of chronic illness
- Use of prescription medications within 2 weeks of collection
- Acute illness within 7 days of collection
- Pregnancy
Key Trial Info
Start Date :
July 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 11 2022
Estimated Enrollment :
691 Patients enrolled
Trial Details
Trial ID
NCT04758208
Start Date
July 12 2021
End Date
February 11 2022
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G1X8